US Stock MarketDetailed Quotes
ADCT ADC Therapeutics
- 4.340
- -0.100-2.25%
Close Apr 26 16:00 ET
- 4.460
- +0.120+2.76%
Post 17:40 ET
358.18MMarket Cap-1476P/E (TTM)
4.510High4.210Low323.50KVolume4.440Open4.440Pre Close1.41MTurnover0.51%Turnover RatioLossP/E (Static)82.53MShares6.04052wk High-2.42P/B273.31MFloat Cap0.36052wk Low--Dividend TTM62.97MShs Float56.590Historical High--Div YieldTTM6.76%Amplitude0.360Historical Low4.352Avg Price1Lot Size
About ADC Therapeutics Company
ADC Therapeutics SA is a clinical-stage biotechnology company. It engages in the research and development and commercialization of targeted antibody drug conjugates for patients with hematological malignancies and solid tumors. Its clinical-stage product candidates include loncastuximab tesirine, camidanlumab tesirine, and ADCT-602. The company was founded by Christopher Martin on June 6, 2011 and is headquartered in Epalinges, Switzerland.
Company Profile
SymbolADCT
Company NameADC Therapeutics
Listing DateMay 15, 2020
Issue Price19.00
Founded2011
CEOMr. Ameet Mallik
MarketNYSE
Employees274
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
AddressBiop?le,Route de la Corniche 3B
CityEpalinges
ProvinceVaud
CountrySwitzerland
Zip Code1066
Phone41-212-653-02-00
Company Executives
- Name
- Position
- Salary
- Ameet Mallik
- Chief Executive Officer and Director
- 3.78M
- Peter J. Graham
- Chief Legal Officer
- --
- Jose Carmona
- Chief Financial Officer
- 1.26M
- Mohamed Zaki, M.D.,PhD
- Chief Medical Officer
- 4.40M
- Ron Squarer
- Chairman of the Board
- 526.73K
- Dr. Jean-Pierre Bizzari, M.D.
- Independent Director
- 197.81K
- Dr. Tyrell J. Rivers, PhD
- Independent Director
- --
- Peter Hug, PhD
- Lead Independent Director
- 212.61K
- Viviane Monges
- Independent Director
- 217.87K
- Thomas Pfisterer
- Independent Director
- 194.30K
- Dr. Victor Sandor, C.M.,M.D.
- Independent Director
- 227.72K
- Robert W. Azelby
- Independent Director
- 127.67K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg